A detailed history of Bleakley Financial Group, LLC transactions in Genmab A/S stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 30,732 shares of GMAB stock, worth $615,254. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,732
Previous 28,536 7.7%
Holding current value
$615,254
Previous $717 Million 4.48%
% of portfolio
0.02%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$23.84 - $28.48 $52,352 - $62,542
2,196 Added 7.7%
30,732 $749 Million
Q2 2024

Aug 12, 2024

SELL
$25.13 - $30.27 $42,695 - $51,428
-1,699 Reduced 5.62%
28,536 $717 Million
Q1 2024

May 08, 2024

BUY
$26.43 - $32.77 $206,735 - $256,326
7,822 Added 34.9%
30,235 $904 Million
Q4 2023

Jan 25, 2024

SELL
$27.94 - $35.44 $43,614 - $55,321
-1,561 Reduced 6.51%
22,413 $714 Million
Q3 2023

Nov 14, 2023

SELL
$35.27 - $42.24 $16,753 - $20,064
-475 Reduced 1.94%
23,974 $846 Million
Q2 2023

Aug 14, 2023

SELL
$37.4 - $42.94 $20,083 - $23,058
-537 Reduced 2.15%
24,449 $929 Million
Q1 2023

May 12, 2023

BUY
$34.88 - $43.22 $98,605 - $122,182
2,827 Added 12.76%
24,986 $943 Million
Q4 2022

Feb 07, 2023

BUY
$33.8 - $47.06 $748,974 - $1.04 Million
22,159 New
22,159 $939 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.2B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.